Difference between revisions of "Combining-Ziprasidone-Lamotrigine"
From Psychiatrienet
(Created page with '{{Drugcombi | base = ziprasidone | add = lamotrigine | info = * Ziprasidone is metabolized by CYP1A2 (minor) and CYP3A4.<ref>Bazire S; Psychotropic drug directory, 2007</ref> ...') |
(No difference)
|
Revision as of 12:49, 15 June 2010
| ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
Adding lamotrigine to ziprasidone.
General information- Ziprasidone is metabolized by CYP1A2 (minor) and CYP3A4.
- Lamotrigine is principally metabolised by UDP-glucuronosyltransferases.
- Ziprasidone is metabolized by CYP1A2 (minor) and CYP3A4.[4]
- This combination of drugs may have possible synergistic effects. There are no reports for pharmacokinetic drug interactions. However, the combination will have additional side effects. [5]
Start lamotrigine- Start lamotrigine according to the general dosing advice.
Cave- Central nervous system- and/or respiratory-depressant effects may be additively or synergistically increased in patients taking multiple drugs that cause these effects. [3]
- ↑ Farmacotherapeutisch Kompas; Toxicologie (dutch)
- ↑ Farmacotherapeutisch Kompas - lamotrigine (dutch)
- ↑ 3.0 3.1 Drugs.com lamotrigine Cite error: Invalid
<ref>tag; name "drugscom" defined multiple times with different content - ↑ Bazire S; Psychotropic drug directory, 2007
- ↑ Freeman et al. Mood stabilizer Combinations: A Review of Safety and Efficacy. Am J Psychiatry 1998;155:12-21
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
